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ABSTRACT 
Methicillin-resistant Staphylococcus aureus (MRSA), an established nosocomial and 
emerging community pathogen associated with many fatalities due to its hyper-virulence and 
multiple drug resistant properties, is on the continuous rise. To update the current status on 
the susceptibility of local MRSA isolates to various classes of antibiotics and to identify the 
most potent antibiotics, thirty-two clinical isolates comprised of hospital acquired (HA) and 
community acquired (CA) infections were investigated by disk diffusion test. Of the 32 
MRSA isolates, 14 (43.75%) and 18 (56.25%) were community and hospital acquired 
MRSA, respectively. All isolates were multiple drug resistant to more than 3 classes of 
antibiotics despite the source or specimen from which it was isolated. The oxacillin MICs for 
all isolates ranged from 2 to ≥ 256 μg/ml. Twenty-five of 26 erythromycin-resistant MRSA 
isolates exhibited an inducible MLSB resistance phenotype while one showed an MS 
phenotype. More than half the isolates (68.75%) were resistant to at least one of the six 
aminoglycosides tested, with netilmicin as the most susceptible. The most effective 
antistaphylococcal agents were linezolid, vancomycin, teicoplanin and 
quinupristin/dalfopristin exhibited 100% susceptibility. Since MRSA is under continuous 
pressure of acquiring multiple drug resistance, it is imperative to focus routine surveillance 
on HA and CA-MRSA strains to monitor and limit the spread of this organism. 
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